Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Phase I trial of KA-34 is currently recruiting participants

April 4, 2018

Novel secretomes disclosed by researchers from Korea

April 4, 2018

Albert Einstein College of Medicine patents MSC-derived microvesicles

April 3, 2018

First patient enrolled in phase IIb trial of AmnioFix Injectable for the treatment of OA of the knee

March 29, 2018

Hernicore approved in Japan to treat lumbar disc herniation

March 27, 2018

EMA committee backs approval of Sandoz's biosimilar infliximab

March 26, 2018

Argenx expands pipeline with ARGX-117 for autoimmune diseases

March 23, 2018

DiscGenics studies IDCT in patients with symptomatic lumbar intervertebral disc degeneration

March 23, 2018

GlaxoSmithKline initiates first-in-human study of GSK-3358699

March 22, 2018

GlaxoSmithKline divulges novel bromodomain and extra-terminal protein inhibitors

March 22, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...